Pharmaceuticals & Osteoporosis


This talk discusses the use of drugs, specifically pharmaceuticals, in the treatment of osteoporosis. Dr. Doug emphasizes the importance of understanding the statistics and risks associated with these drugs. Two main classes of drugs are discussed: bisphosphonates and denosumab. The Dr. Doug expresses concerns about the decimation of bone metabolism caused by these drugs. Other drugs, such as analogs of parathyroid hormone and calcitonin, are also mentioned. Dr. Doug introduces the concept of peptides as a potential alternative to drugs, although their efficacy and safety are not well-studied. The talk concludes by highlighting the need for a comprehensive plan and considering the long-term implications of drug use.

  • Understanding the statistics and risks associated with osteoporosis drugs is important
  • Bisphosphonates and denosumab are the two main classes of drugs used for osteoporosis
  • Decimation of bone metabolism is a concern with these drugs
  • Analogs of parathyroid hormone and calcitonin are alternative options
  • Peptides may be a potential alternative to drugs, but more research is needed
  • A comprehensive plan and consideration of long-term implications are important in the treatment of osteoporosis

Additional Resources